Protease-sparing regimen
Protease-sparing regimen
Protease-sparing regimen (pronunciation: proh-tee-ayss-spar-ing reh-juh-men) is a type of antiretroviral therapy used in the treatment of HIV and AIDS.
Etymology
The term "protease-sparing" comes from the fact that this regimen does not include protease inhibitors, a class of antiretroviral drugs. "Regimen" is derived from the Latin word "regimen", meaning "rule" or "management".
Definition
A protease-sparing regimen is a combination of antiretroviral drugs that does not include protease inhibitors. This type of regimen is often used in the initial treatment of HIV infection, especially in patients who have not previously been treated with antiretroviral drugs. The goal of a protease-sparing regimen is to suppress the replication of the HIV virus while minimizing the risk of drug resistance and side effects.
Related Terms
- Antiretroviral therapy: Treatment with drugs that inhibit the ability of the HIV virus to multiply in the body.
- Protease inhibitors: A class of antiretroviral drugs that prevent the HIV virus from replicating by inhibiting the action of an enzyme called protease.
- HIV: Human Immunodeficiency Virus, the virus that causes AIDS.
- AIDS: Acquired Immunodeficiency Syndrome, a disease of the immune system caused by the HIV virus.
See Also
External links
- Medical encyclopedia article on Protease-sparing regimen
- Wikipedia's article - Protease-sparing regimen
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski